Skip to main content
. 2022 Aug 1;14:935176. doi: 10.3389/fnagi.2022.935176

Table 4.

Results of Direct meta-analysis.

Variable Group k SMD (95%CI) Direct Evidence I2 (%) Model
UPDRS III LP-HI-AE VS. CON 4 −0.36 [−0.90; 0.17] 0.76 0 Fixed
LP-HI-RT VS. CON 3 −0.20 [−0.79; 0.038] 0.87 0 Fixed
LP-MI-AE VS. CON 1 −0.26 [−1.09; 0.57] 0.58
SP-HI-AE VS. CON 2 −0.31 [−1.10; 0.47] 0.8 0 Fixed
SP-LI-RT VS. CON 1 0.21 [−0.91; 1.34] 0.6
LP-HI-AE VS. LP-HI-RT 1 −1.28 [−2.74; 0.18] 0.21
LP-HI-AE VS. LP-MI-AE 1 0.21 [−0.62; 1.04] 0.58
SP-HI-AE VS. SP-LI-RT 1 −0.22 [−1.35; 0.91] 0.6
TUG LP-HI-AE VS. CON 3 −0.39 [−0.82; 0.04] 0.85 0 Fixed
LP-HI-RT VS. CON 1 −0.00 [−0.72; 0.72] 0.58
LP-HI-AE VS. LP-HI-RT 1 −0.44 [−1.16; 0.27] 0.58
6MWT LP-HI-AE VS. CON 3 0.21 [−0.68; 1.10] 0.84 0.81 Random
LP-LI-AE VS. CON 1 1.06 [−0.40; 2.51] 0.59
LP-HI-AE VS. LP-LI-AE 1 −1.71 [−3.19;−0.23] 0.57
TWM LP-HI-AE VS. CON 3 −0.20 [−0.64; 0.34] 0.69 0 Fixed
LP-HI-RT VS. CON 1 0.04 [−1.05; 1.14] 0.54
LP-LI-AE VS. CON 2 0.17 [−0.27; 0.61] 0.73 0 Fixed
LP-HI-AE VS. LP-HI-RT 1 0.05 [−1.06; 1.17] 0.52
LP-HI-AE VS. LP-LI-AE 1 −0.20 [−0.78; 0.39] 0.52
PDQ-39 LP-HI-AE VS. CON 3 0.18 [−0.28; 0.64] 0.83 0.05 Fixed
LP-HI-RT VS. CON 1 −0.00 [−0.72; 0.72] 0.59
LP-HI-AE VS. LP-HI-RT 1 0.66 [−0.77; 1.38] 0.58

K, Number of studies; LP-HI-AE, long period high intensity aerobic exercise; LP-HI-RT, long period high intensity resistance training; LP-MI-AE, long period moderate intensity aerobic exercise; SP-HI-AE, short period high intensity aerobic exercise; SP-LI-RT, short period low intensity resistance training; LP-HI-AE, long period high intensity aerobic exercise; LP-HI-RT, long period high intensity resistance training; LP-LI-AE, long period low intensity aerobic exercise; UPDRSIII, Unified Parkinson's Disease Rating Scale; PDQ39, Parkinson's Disease Questionnaire 39; TUG, Timed Up and Go; TMW, 10-meter walk test; 6MWT, 6-min walk test.